Pan-cancer mapping of transcript-driven subcellular localization switching suggests candidate mechanisms of immune evasion and immunotherapy resistance
Year: 2026
Type: article
Abstract: Differential splicing has been extensively characterized at the level of individual splicing events, yet a systematic pan-cancer characterization of transcript-driven subcellular localization switching is lacking. Using matched tumour and healthy tissue samples across 14 TCGA cancer types, we predicted the subcellular localization of every protein-coding isoform and grouped transcript expression into three localization classes: transmembrane/cell surface (TM), secreted (Sec), and intracellular (Int). We defined a localization switch as a tumour-associated redistribution of transcript usage between these localization classes and identified 977 genes, corresponding to 3,723 gene-by-cancer localization-switch events, many of which recurred across multiple cancer types. Among these, we highlight representative switches with potential implications for immune regulation, intrinsic cancer-cell function, and soluble decoy formation. Together, our results establish transcript-driven subcellular localization switching as a recurrent consequence of alternative splicing in cancer and provide a framework and resource for investigating its potential roles in immune evasion, therapeutic resistance, and cancer adaptation.
Source: Frontiers in Molecular Medicine
Institutions: University of Copenhagen, LEO Foundation, Novo Nordisk Foundation
Language: English
Topic: RNA Research and Splicing
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,353
Award: G4129004604
OpenAlex ID: W7233934810
